Achyut Healthcare Limited reported a net profit of ₹31.57 lakh for the financial year ended March 31, 2026, compared to ₹51.47 lakh in the previous year. Revenue from operations surged to ₹1,159.47 lakh in FY26 from ₹304.75 lakh in FY25, driven by its pharmaceutical business segment. The board of directors approved the audited financial results for the fourth quarter and the full year on May 27, 2026.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹5.67 lakh, while revenue from operations reached ₹438.64 lakh. Total income for the quarter stood at ₹452.55 lakh. The company's total expenses for the year were reported at ₹1,159.57 lakh, up from ₹331.85 lakh in the prior year.

Financial Performance

The company’s earnings per share (EPS) for the basic and diluted categories was reported at ₹0.0134 for FY26, compared to ₹0.0218 in FY25. The paid-up equity share capital increased to ₹2,413.57 lakh as of March 31, 2026, from ₹2,355.57 lakh in the previous year, following a preferential issue of 58,00,000 equity shares allotted on March 23, 2026, at an issue price of ₹6 per share.

Board Decisions and Compliance

The board approved the appointment of M/s. Mohta Khetawat & Co., Chartered Accountants, as the internal auditor for the financial year 2026-2027. The firm holds a Firm Registration Number (FRN) of 140845W. Additionally, the board authorized Managing Director and CFO Mr. Jigen J. Modi to fix the record date, book closure dates, and other logistics for the proposed Annual General Meeting. The meeting also took note of the annual disclosure of interest by directors and the declaration by independent directors.

Accounting Standards Transition

Achyut Healthcare adopted Indian Accounting Standards (Ind AS) effective from April 1, 2025, with a transition date of April 1, 2024, following its migration to the Main Board of BSE Limited. The statutory auditors, Doshi Doshi & Co., provided an unmodified opinion on the financial results, noting the first-time adoption of Ind AS. The comparative financial information for the corresponding period ended March 31, 2025, has been restated in accordance with the new standards.

Achyut Healthcare Limited , headquartered in Ahmedabad, Gujarat, has received listing approval from BSE Limited for the issuance of 58,00,000 equity shares of Re.1/- each at a price of Rs.6/- on a preferential basis to both promoters and non-promoters. The approval was communicated by BSE vide letter reference number LOD/PREF/SS/FIP/187/2026-27, dated May 07, 2026. The shares carry a face value of Re.1/- each and are being issued at a premium of Rs.5/-, bringing the total issue price to Rs.6/- per share.

Key Details of the Listing Approval

The listing approval covers a specific range of equity shares, as outlined in the BSE communication. The following table summarises the key parameters of the preferential allotment:

Regulatory Compliance Requirements

BSE has stipulated that trading approval for the aforementioned shares will be granted only upon fulfilment of specific compliance conditions. The company is required to submit the following documents to the Exchange:

• Listing approval from the National Stock Exchange of India Ltd. (if applicable)
• Confirmation letters from NSDL/CDSL confirming the crediting of shares to respective beneficiary accounts or admission of capital into the depository system
• Confirmation letters from NSDL/CDSL regarding lock-in of pre-preferential holdings (if applicable)

The company must also ensure compliance with the provisions of Regulation 167 of SEBI (ICDR) Regulations. Additionally, as per Schedule XIX of the ICDR Regulations and SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, the company is required to apply for trading approval to the stock exchange within seven working days from the date of grant of listing approval. Non-compliance with this requirement will attract fines as specified in the said SEBI circular.

Shareholding Pattern Disclosure

BSE has further noted that in the event the preferential allotment results in a change exceeding two per cent of the total paid-up share capital of the company, Achyut Healthcare Limited will be required to file the updated shareholding pattern in XBRL mode, as mandated under Regulation 31(1)(c) of SEBI LODR Regulations, 2015.

Management Communication

The disclosure was made by Jigen Jagdishbhai Modi, Managing Director of Achyut Healthcare Limited, through a formal communication to BSE Limited. The listing approval letter from BSE was signed by Marian D'souza, Assistant Vice President, and Sahana Shetty, Deputy Manager, on behalf of the Exchange. The company's registered office is located at 504, Iscon Elegance, Circle P, S.G. Highway, Ahmedabad-380 015, Gujarat.